| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0014-2999(03)02043-0 |
| P698 | PubMed publication ID | 12921859 |
| P50 | author | Martine Jandrot-Perrus | Q57068013 |
| Olivier Meilhac | Q57244186 | ||
| P2093 | author name string | Jean Baptiste Michel | |
| Mounsif Haloui | |||
| P2860 | cites work | New insights into the role of nuclear factor-KB, a ubiquitous transcription factor in the initiation of diseases | Q23923136 |
| The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators | Q29547887 | ||
| A receptor-mediated pathway for cholesterol homeostasis | Q29616158 | ||
| Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group | Q29619842 | ||
| Cellular antioxidant effects of atorvastatin in vitro and in vivo | Q30809431 | ||
| Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. | Q32041861 | ||
| How the protease thrombin talks to cells | Q33740137 | ||
| The role of Rho in G protein-coupled receptor signal transduction | Q33932175 | ||
| Recent advances towards understanding redox mechanisms in the activation of nuclear factor kappaB. | Q33989830 | ||
| Clinically relevant differences between the statins: implications for therapeutic selection | Q34093408 | ||
| The structure of the catalytic portion of human HMG-CoA reductase | Q34101174 | ||
| Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6. | Q34244878 | ||
| Nuclear factor kappa-B and the heart | Q34333586 | ||
| Role of High-Affinity Thrombin Receptors in Postclotting Cellular Effects of Thrombin | Q35227684 | ||
| Vascular smooth muscle cells differ from other smooth muscle cells: predominance of vimentin filaments and a specific alpha-type actin | Q35306274 | ||
| Protease-activated receptors start a family | Q35771547 | ||
| Role of thrombin receptor in breast cancer invasiveness | Q36618228 | ||
| A cytokine network in human diploid fibroblasts: interactions of beta-interferons, tumor necrosis factor, platelet-derived growth factor, and interleukin-1 | Q36833475 | ||
| Thrombin hypothesis of thrombus generation and vascular lesion formation | Q40597977 | ||
| Membrane association and targeting of prenylated Ras-like GTPases | Q40857389 | ||
| Inhibition of the mevalonate pathway: benefits beyond cholesterol reduction? | Q40933208 | ||
| Cellular consequences of thrombin-receptor activation | Q40952373 | ||
| Statins do more than just lower cholesterol | Q41169571 | ||
| Hypoxic stress induces cardiac myocyte-derived interleukin-6. | Q41363376 | ||
| Simvastatin reduces neointimal thickening in low-density lipoprotein receptor-deficient mice after experimental angioplasty without changing plasma lipids | Q44047528 | ||
| Statins as potent antiinflammatory drugs | Q44179182 | ||
| Anti-thrombotic effects of atorvastatin--an effect unrelated to lipid lowering | Q44255221 | ||
| Rho GTPases | Q47724821 | ||
| Expression of interleukin-6 in atherosclerotic lesions of male ApoE-knockout mice: inhibition by 17beta-estradiol. | Q50865979 | ||
| Production of hybridoma growth factor by human monocytes. | Q52827130 | ||
| Interleukin 6 gene transcripts are expressed in atherosclerotic lesions of genetically hyperlipidemic rabbits | Q68211345 | ||
| Interaction of human alpha-thrombin and gamma-thrombin with antithrombin III, protein C and thrombomodulin | Q70118136 | ||
| Relaxant and contractile responses of porcine pulmonary arteries to thrombin and thrombin receptor activating peptides | Q71604011 | ||
| Interleukin 6 gene transcripts are expressed in human atherosclerotic lesions | Q71995005 | ||
| Vesnarinone, a new inotropic agent, inhibits cytokine production by stimulated human blood from patients with heart failure | Q72285080 | ||
| Selective isolation of rat aortic wall layers and their cell types in culture--application to converting enzyme activity measurement | Q72622071 | ||
| Elevated plasma interleukin-6 levels in patients with acute myocardial infarction | Q72630338 | ||
| Targeting Rho in cardiovascular disease | Q73015340 | ||
| Expression of NADH/NADPH oxidase p22phox in human coronary arteries | Q73049808 | ||
| Atorvastatin reduces NF-kappaB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells | Q73176746 | ||
| Effects of pravastatin in 3260 patients with unstable angina: results from the LIPID study | Q73328285 | ||
| Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors | Q73783792 | ||
| Pravastatin attenuates cardiovascular inflammatory and proliferative changes in a rat model of chronic inhibition of nitric oxide synthesis by its cholesterol-lowering independent actions | Q74060441 | ||
| Lipoprotein(a) and lipoprotein profile in healthy centenarians: a reappraisal of vascular risk factors | Q74423002 | ||
| Rat interleukin 6: expression in recombinant Escherichia coli, purification and development of a novel ELISA | Q74629240 | ||
| The nuclear factor-kappa B/inhibitor of kappa B autoregulatory system and atherosclerosis | Q77542530 | ||
| HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis | Q77700153 | ||
| Thrombin regulates the expression of proangiogenic cytokines via proteolytic activation of protease-activated receptor-1 | Q77753214 | ||
| P433 | issue | 2-3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 175-184 | |
| P577 | publication date | 2003-08-01 | |
| P1433 | published in | European Journal of Pharmacology | Q1376712 |
| P1476 | title | Atorvastatin limits the pro-inflammatory response of rat aortic smooth muscle cells to thrombin | |
| P478 | volume | 474 |
| Q35680633 | Amlodipine and atorvastatin in atherosclerosis: a review of the potential of combination therapy |
| Q43116219 | Atorvastatin reduces tissue damage in rat ovaries subjected to torsion and detorsion: biochemical and histopathologic evaluation |
| Q26991619 | Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system |
| Q44628998 | Counter-regulation by atorvastatin of gene modulations induced by L-NAME hypertension is associated with vascular protection |
| Q43812550 | Effect of a single high loading dose of rosuvastatin on percutaneous coronary intervention for acute coronary syndromes |
| Q39826210 | Fluvastatin inhibits expression of the chemokine MDC/CCL22 induced by interferon-gamma in HaCaT cells, a human keratinocyte cell line |
| Q38914050 | Functional Heterogeneity of Nadph Oxidases in Atherosclerotic and Aneurysmal Diseases |
| Q47794757 | IL-10 inhibits vascular smooth muscle cell activation in vitro and in vivo |
| Q33739287 | NADPH oxidases: functions and pathologies in the vasculature |
| Q27025415 | New insights into intracellular locations and functions of heme oxygenase-1 |
| Q36088110 | Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials. |
Search more.